Navigation Links
PathSensors receives expanded license from MIT for CANARY Technology
Date:7/10/2020

PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to include clinical applications for CANARY™ technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly sensitive assays will help to address the shortage of COVID-19 testing capabilities in the United States.

The company’s core business is environmental testing in fields such as building protection, mail security, food safety, and agriculture. Test panels for other infectious diseases will follow in future years.

“PathSensors originally developed CANARY™ technology for commercial use in 2012,” stated PathSensors’ President, Ted Olsen. “Now 8 years later, we are bringing CANARY™ to the healthcare field to provide rapid and highly sensitive detection solutions for a major public health crisis.”

About CANARY™
CANARY™ is a biosensor technology that delivers extremely rapid detection of pathogens with high sensitivity and specificity. Originally developed by scientists at MIT–Lincoln Laboratory to combat bioterrorism threats, CANARY™ has been licensed and commercialized by PathSensors, Inc.

About PathSensors, Inc.
PathSensors is a leading environmental testing company offering cutting-edge pathogen detection capabilities to a variety of industries including food safety, agriculture, infectious disease, and bioterrorism. The company makes the world a safer place by detecting pathogens that can cause sickness or worse while creating high technology jobs in the state of Maryland.

Read the full story at https://www.prweb.com/releases/pathsensors_receives_expanded_license_from_mit_for_canary_technology/prweb17246187.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. PathSensors Inc. Announced the Completion of Phase I of a SBIR
2. Roger Lawrence Appointed to PathSensors, Inc Scientific Advisory Board
3. PathSensors' Ralstonia and Phytophthora Assays Validated by the USDA
4. Bio-Tech Firm PathSensors Enters Fast-Growing Chinese Pathogen Detection Market
5. Bio-Tech Firm PathSensors Launches High-Throughput Diagnostics for Plant Safety at 2017 American Phytopathological Society (APS) Annual Conference
6. PathSensors Demonstrates Breakthrough Mail Security Screening Solution at National Postal Forum 2017
7. PathSensors Launches Low Cost, High Speed Anthrax and Bio Threat Detection Solution for Mail Security Screening
8. PathSensors to Develop and Commercialize Bio Sensor Technology to Combat Citrus Greening Disease (HLB)
9. Dr. Greg Lamka joins PathSensors Scientific Advisory Board
10. PathSensors Moves to the Columbus Center in Baltimores Inner Harbor
11. Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal Purchasing ... to its membership, recently named BioFit Engineered Products an Awarded Vendor. ... purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted pricing without ...
(Date:6/28/2020)... ROCKY HILL, Conn. (PRWEB) , ... June 25, ... ... systems company formed to advance photodynamic therapy for treating cancer, today announced the ... Buffalo, New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights ...
Breaking Biology Technology:
(Date:7/2/2020)... REDWOOD CITY, Calif. (PRWEB) , ... July 01, ... ... stage biotech company, presented its phase 1a findings of Neihulizumab, a biologic for ... annual conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid Africa, a ... UK supplier and manufacturer of innovative portable renewable energy equipment, have announced the ... against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable ...
Breaking Biology News(10 mins):